Encompass Health Future Growth
Future criteria checks 2/6
Encompass Health is forecast to grow earnings and revenue by 9.6% and 8.7% per annum respectively. EPS is expected to grow by 6.8% per annum. Return on equity is forecast to be 21.3% in 3 years.
Key information
9.6%
Earnings growth rate
6.8%
EPS growth rate
Healthcare earnings growth | 20.7% |
Revenue growth rate | 8.7% |
Future return on equity | 21.3% |
Analyst coverage | Good |
Last updated | 16 Dec 2024 |
Recent future growth updates
Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Recent updates
Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors
Dec 10Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings
Oct 21Is Encompass Health (NYSE:EHC) Using Too Much Debt?
Oct 03Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price
May 23Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Encompass Health's (NYSE:EHC) Dividend Will Be $0.15
Mar 09What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?
Feb 25Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Feb 07We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Jan 09Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health declares $0.15 dividend
Feb 23Encompass Health: Incremental Returns On Capital Key, Confirm Buy
Feb 17Encompass Health 2023 adjusted earnings per share estimate range below consensus
Feb 07Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M
Oct 26Encompass Health declares $0.15 dividend
Oct 19Encompass health to build a rehabilitation hospital in the Villages, Florida
Sep 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,333 | 534 | 195 | N/A | 8 |
12/31/2025 | 5,827 | 485 | 312 | 901 | 12 |
12/31/2024 | 5,349 | 440 | 348 | 903 | 12 |
9/30/2024 | 5,215 | 432 | 270 | 925 | N/A |
6/30/2024 | 5,071 | 409 | 215 | 872 | N/A |
3/31/2024 | 4,957 | 387 | 239 | 862 | N/A |
12/31/2023 | 4,801 | 362 | 268 | 851 | N/A |
9/30/2023 | 4,692 | 357 | 241 | 822 | N/A |
6/30/2023 | 4,574 | 336 | 97 | 677 | N/A |
3/31/2023 | 4,450 | 280 | 144 | 715 | N/A |
12/31/2022 | 4,349 | 256 | 122 | 706 | N/A |
9/30/2022 | 4,254 | 232 | 81 | 657 | N/A |
6/30/2022 | 4,175 | 242 | 216 | 765 | N/A |
3/31/2022 | 3,844 | 253 | 216 | 776 | N/A |
12/31/2021 | 4,015 | 298 | 170 | 716 | N/A |
9/30/2021 | 4,187 | 316 | 381 | 872 | N/A |
6/30/2021 | 4,350 | 318 | 408 | 868 | N/A |
3/31/2021 | 4,693 | 304 | 410 | 834 | N/A |
12/31/2020 | 3,566 | 193 | 300 | 705 | N/A |
9/30/2020 | 4,614 | 265 | 244 | 641 | N/A |
6/30/2020 | 4,602 | 285 | 169 | 582 | N/A |
3/31/2020 | 4,663 | 342 | 89 | 505 | N/A |
12/31/2019 | 4,605 | 358 | 231 | 635 | N/A |
9/30/2019 | 4,517 | 317 | 238 | 598 | N/A |
6/30/2019 | 4,423 | 308 | 362 | 682 | N/A |
3/31/2019 | 4,355 | 309 | 417 | 706 | N/A |
12/31/2018 | 4,277 | 290 | 486 | 762 | N/A |
9/30/2018 | 4,190 | 339 | 476 | 735 | N/A |
6/30/2018 | 4,104 | 316 | N/A | 712 | N/A |
3/31/2018 | 4,003 | 288 | N/A | 694 | N/A |
12/31/2017 | 3,914 | 271 | N/A | 658 | N/A |
9/30/2017 | 3,841 | 260 | N/A | 642 | N/A |
6/30/2017 | 3,771 | 256 | N/A | 645 | N/A |
3/31/2017 | 3,710 | 256 | N/A | 646 | N/A |
12/31/2016 | 3,643 | 247 | N/A | 640 | N/A |
9/30/2016 | 3,576 | 228 | N/A | 616 | N/A |
6/30/2016 | 3,432 | 217 | N/A | 602 | N/A |
3/31/2016 | 3,280 | 198 | N/A | 552 | N/A |
12/31/2015 | 3,116 | 181 | N/A | 502 | N/A |
9/30/2015 | 2,857 | 173 | N/A | 438 | N/A |
6/30/2015 | 2,678 | 172 | N/A | 415 | N/A |
3/31/2015 | 2,520 | 204 | N/A | 440 | N/A |
12/31/2014 | 2,374 | 208 | N/A | 445 | N/A |
9/30/2014 | 2,336 | 144 | N/A | 476 | N/A |
6/30/2014 | 2,303 | 148 | N/A | 479 | N/A |
3/31/2014 | 2,266 | 228 | N/A | 456 | N/A |
12/31/2013 | 2,247 | 229 | N/A | 470 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EHC's forecast earnings growth (9.6% per year) is above the savings rate (2.6%).
Earnings vs Market: EHC's earnings (9.6% per year) are forecast to grow slower than the US market (15.2% per year).
High Growth Earnings: EHC's earnings are forecast to grow, but not significantly.
Revenue vs Market: EHC's revenue (8.7% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: EHC's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EHC's Return on Equity is forecast to be high in 3 years time (21.3%)
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:08 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Encompass Health Corporation is covered by 38 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null RESEARCH DEPARTMENT | Avondale Partners |
Matthew Gillmor | Baird |
Ishan Majumdar | Baptista Research |